Clinical Trial Update: A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing safety and immunogenicity of the bOPV vaccine from Bilthoven Biologicals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunity to Oral Polio Vaccine
• Poliovirus Vaccination-induced Immunity

Drugs mentioned

• bOPV (bivalent oral polio vaccine)

Snippet

Sponsor: Bilthoven Biologicals | Conditions: Immune Response to Oral Polio Vaccine | Phase 3 | Status: COMPLETED